ÓSKARE CAPITAL STRENGTHENS TEAM WITH TWO NEW MEMBERS
Óskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in the investment…
Read more
Media
- News
- Insights
- Media contact details
News
Broughton bids farewell to Mercia
Mercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…
Read moreCentral Bank signs off on €150m legal cannabis fund
THE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…
Read moreMedical cannabis private equity fund established
Ireland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…
Read moreCannabis thérapeutique : un fonds veut doper l’écosystème européen
Oskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…
Read moreOctarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives
Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…
Read moreInsights
The Medical Cannabis Opportunity in the EU Stimulus Package
The good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…
Read moreMedia contact details
Alexandre OUIMET STORRS
- phone : +33 (0) 6 68 29 57 94
- email: alex@oskarecapital.com
Nicola BROUGHTON
- email: nicola@oskarecapital.com